HutchMED (China) LIMITED (HMDCF) Revenue 2016–2025
HutchMED (China) LIMITED (HMDCF) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$548.5MFY2025 · since FY2016: $216.1M → $548.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $548.5M | -13.0% |
| FY2024 | $630.2M | -24.8% |
| FY2023 | $838.0M | +96.5% |
| FY2022 | $426.4M | +19.7% |
| FY2021 | $356.1M | +56.2% |
| FY2020 | $228.0M | +11.3% |
| FY2019 | $204.9M | -4.3% |
| FY2018 | $214.1M | -11.2% |
| FY2017 | $241.2M | +11.6% |
| FY2016 | $216.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HMDCF financial trends
HMDCF Net incomeHMDCF Net marginHMDCF Gross profitHMDCF Gross marginHMDCF Operating incomeHMDCF Operating marginHMDCF Operating cash flowHMDCF Free cash flowHMDCF Capital expendituresHMDCF Return on equityHMDCF Stock buybacksHMDCF Dividends paidHMDCF Total assetsHMDCF Total liabilitiesHMDCF Shareholders’ equityHMDCF overview →